Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Immunohistochemistry for the autophagy markers LC3B and p62 was applied on tumor tissue from 149 EAC patients treated with neoadjuvant chemotherapy, including pre- and post-therapeutic samples (62 matched pairs).
|
29897944 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
High levels of p62 c-myc were associated with well differentiated tumours.
|
2679850 |
1989 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In this context, we also discuss the critical role of the signaling adaptor p62/Sequestosome 1(SQSTM1) in adipocytes in mediating tumor-induced fat reprograming and the feedback of adipose tissue on tumor aggressiveness via osteopontin and its potential implications in obesity-promoted cancer and fat cachexia.
|
30198373 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Additionally, autophagy markers LC3II/I (<i>p</i> < 0.05), Beclin-1 (<i>p</i> < 0.01), and P62 (<i>p</i> < 0.05) increased in the skeletal muscle of tumor-bearing mice.
|
30713500 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Immunohistochemically, c-myc p62 positive tumor cells were found in 24 cases (46.2%), while the stromal cells around the tumor cells showed c-myc p62 immunoreactivity in all cases (100%).
|
2188234 |
1990 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The p62 proteins were elevated and mainly located in the cytoplasm in some types of tumor compared with the normal tissues.
|
30410612 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Our findings show how p62 helps maintain intracellular pools of GSH needed to limit mitochondrial dysfunction in tumor cells with elevated mTORC1, highlighting p62 and redox homeostasis as nodal vulnerabilities for therapeutic targeting in these tumors.<i></i>.
|
28512249 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
ATF4 upregulation by p62 deficiency in the stroma activates glucose carbon flux through a pyruvate carboxylase-asparagine synthase cascade that results in asparagine generation as a source of nitrogen for stroma and tumor epithelial proliferation.
|
28988820 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Since p62 may also be involved in pro-apototic signal transduction, the loss of p62 expression in neuroendocrine neoplasms of the pancreas may render the tumour cells less sensitive to pro-apototic signals.
|
15926199 |
2005 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Mechanistically, the Lmdd-MPFG vaccine activates the NF-κB pathway in the tumor-associated macrophages (TAMs) through the TLR2 and MyD88 pathway, and recruits p62 to activate the autophagy pathway.
|
31659256 |
2020 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Inhibition of LSD1 reduces both tumor growth and p62 protein degradation <i>in vivo</i>.
|
29088798 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Correlation of quantitative dot blotting of tumour mRNA to flow cytometric p62 c-myc expression was good (r = 0.87, P less than 0.01).
|
1874294 |
1991 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Phosphorylated p62/Sqstm1 accumulates in tumour regions positive for hepatitis C virus (HCV).
|
27345495 |
2016 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer.
|
25925890 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Here we report that tumor-suppressor HACE1, a ubiquitin ligase, ubiquitylates OPTN and promotes its interaction with p62/SQSTM1 to form the autophagy receptor complex, thus accelerating autophagic flux.
|
25026213 |
2014 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Entrectinib demonstrated significant anti-tumor activity in a patient with NSCLC harboring an SQSTM1-NTRK1 gene rearrangement, indicating that entrectinib may be an effective therapy for tumors with NTRK gene rearrangements, including those with central nervous system metastases.
|
26565381 |
2015 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Evidence has shown that p62 is upregulated in different cancers and promotes tumour growth, such as in liver cancer and lung cancer.
|
30793399 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
As a tumor-suppression mechanism, autophagy deficiency is common in tumors, which results in aberrant accumulation of p62 and activates p62-regulated pathways, such as activation of mTOR in nutrient sensing, and the activation of the Keap1-Nrf2 pathway for antioxidant stress, which are associated with cancer development.
|
31802896 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tumor tissue katanin P60 expression correlates with lymph node metastasis and worse prognosis in patients with breast cancer: A cohort study.
|
29103029 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Thus, p62 is an anti-inflammatory tumor suppressor that acts through the modulation of metabolism in the tumor stroma.
|
25002027 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
By dividing patients into 2 levels of tumor expression of p62 c-myc, there was a trend for improved survival in patients with low expression (chi 2(1) = 3.65, p = 0.056).
|
2200214 |
1990 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tumor SQSTM1 expression is inversely associated with FOXP3<sup>+</sup> cell density in colorectal cancer tissue, suggesting a possible role of SQSTM1-expressing carcinoma cells on regulatory T cells in the tumor microenvironment.
|
28405513 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Together, our studies demonstrate that p62 and autophagy synergize to promote tumor growth, suggesting that inhibition of both pathways could be more effective than targeting either alone for cancer therapy.
|
24888590 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Examination of ovarian cancer tissue microarray further showed that the levels of SQSTM1, DICER1 and AGO2 in the tumor were higher than those in the non-tumor cells and negatively correlated with the levels of autophagy and MIRLET7A-3P.
|
30081720 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
TRB3 links insulin/IGF to tumour promotion by interacting with p62 and impeding autophagic/proteasomal degradations.
|
26268733 |
2015 |